Free radicals and antioxidant status in acute myocardial infarction patients with and without diabetes mellitus

Bangladesh Medical Research Council Bulletin

Volumn 35, Issue 3, 2009, Pages 95-100

  Deepa, Mathiyalagan ^a   Pasupathi, Palanisamy ^a   Sankar, K B Vidhya ^a   Rani, P ^a   Kumar, S P Satish ^a  

^a Raajam Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CERULOPLASMIN; FREE RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; BLOOD; CASE CONTROL STUDY; COMORBIDITY; HEART INFARCTION; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CERULOPLASMIN; COMORBIDITY; DIABETES MELLITUS; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 77953909023     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v35i3.2999     Document Type: Article

References (34)

1. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med. 2000; 342: 1040-42.
2. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140-44.
3. Williams IL, Noronha B, Zaman AG. The management of acute myocardial infarction in patients with diabetes mellitus. Br J Diabetes Vasc Dis. 2003; 3: 319-24.
4. Kasap S, Gonenc A, Sener DE, Hisar I. Serum Cardiac Markers in Patients with Acute Myocardial Infarction: Oxidative Stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem Nutr. 2007; 41: 50-57. (Pubitemid 47266172)
5. Giselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool assess redox status: Critical view and experimental data. Free Rad. Biol Med. 2000; 29: 1106-14.
6. Donald DH. Oxidative stress and vascular disease. Arteriosclerosis Thrombosis Vascular Biol. 2005; 26: 689-95.
7. Mahboob M, Rahman MF, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005; 46: 322-24.
8. Xi LS, Fan HF, Jian GZ, Ryoji N, Ru ZW, Qiang LZ, Mei ZZ, Mei Z, Xie D, Bao WG, Xun Z. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arteriosclerosis Thrombosis Vascular Biol. 2006; 26: 1156-62.
9. Firoozrai M, Nourbakhsh M, Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res Clin Practice 2007; 77: 427-32.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-02.
11. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1978; 45: 337-51.
12. Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med. 1961; 58: 161-68.
13. Kakkar PS, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984; 21:130-32.
14. Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972; 47: 389-94.
15. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82: 70-77.
16. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: Biochemical roles as a component of glutathione peroxidase. Science 1973; 179: 588-90.
17. Bradley DW, Hombeck CL. Clinical evaluation and improved TFA micro method for plasma and serum vitamin (A) β-carotein. Biochem Med. 1973; 7: 78-86.
18. Baker H, Frank O, De Angelis B, Feingold S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int. 1980; 21: 531-36.
19. Roe HJ, Kuether CA. Detection of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivative of dehydro ascorbic acid. J Biol Chem. 1943; 147: 399-07.
20. Mak KH, Topol EJ. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol. 2000; 35: 563-68.
21. Tomas M, Latorre G, Senti M, Marrugat J. The antioxidant function of high-density lipoproteins: A new paradigm in atherosclerosis. Rev Esp Cardiol. 2004; 57: 557-69.
22. Ambrose JA, RS Barua. The pathophysiology of cigarette smoking and cardiovascular disease. J Am Coll Cardiol. 2004; 43: 1731-37.
23. Kharb S, Singh GP. Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction. Clin Chim Acta 2000; 302: 213-19.
24. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I. Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure. Adv Ther. 2006; 23: 1060-67.
25. Gupta S, Singh KN, Bapat V, Mishra V, Agarwal DK, Gupta P. Diagnosis of acute myocardial infarction: CK- MB versus CTN-T in Indian patients. Ind J Clin Biochem. 2008; 23: 89-91.
26. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: A population-based study. Diabetes 2003; 52: 442-47.
27. Pasupathi P, Rao YY, Farook J, Saravanan G, Bakthavathsalam G. Oxidative stress, cardiac markers and antioxidant status in patients with acute myocardial infarction. Eur J Sci Res. 2009; 27: 275-85.
28. Patil N, Chavan V, Karnik ND. Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem. 2007; 22: 45-51. (Pubitemid 46411199)
29. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002; 347: 5-12. (Pubitemid 34728951)
30. Zairis MN, Manousakis SJ, Stefanidis AS, Papadaki OA, Andrikopoulos GK, Olympios CD, Hadjissavas JJ, Argyrakis SK, Foussas SG. C-reactive protein levels and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J. 2002; 144: 782-89.
31. Nikfardjam M, Mullner M, Schreiber W, Oschatz E, Exner M, Domanovits H, Laggner AN, Huber K. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med. 2000; 247: 341-45.
32. Berger AK, Breall JA, Gersh BJ, Johnson AE, Oetgen WJ, Marciniak TA, Schulman KA. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the co-operative cardiovascular project). Am J Cardio. 2001; 87: 272-77.
33. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. JAMA-India 2004; 3: 34-41.
34. Acevedo M, Foody JM, Pearce GL, Sprecher DL. Fibrinogen: Association with cardiovascular events in an outpatient clinic. Am Heart J. 2002; 143: 277-82.